529 related articles for article (PubMed ID: 33693966)
21. [A primer on radiomics].
Murray JM; Kaissis G; Braren R; Kleesiek J
Radiologe; 2020 Jan; 60(1):32-41. PubMed ID: 31820014
[TBL] [Abstract][Full Text] [Related]
22. Machine learning-based radiomics strategy for prediction of cell proliferation in non-small cell lung cancer.
Gu Q; Feng Z; Liang Q; Li M; Deng J; Ma M; Wang W; Liu J; Liu P; Rong P
Eur J Radiol; 2019 Sep; 118():32-37. PubMed ID: 31439255
[TBL] [Abstract][Full Text] [Related]
23. A Machine Learning Model Based on PET/CT Radiomics and Clinical Characteristics Predicts Tumor Immune Profiles in Non-Small Cell Lung Cancer: A Retrospective Multicohort Study.
Tong H; Sun J; Fang J; Zhang M; Liu H; Xia R; Zhou W; Liu K; Chen X
Front Immunol; 2022; 13():859323. PubMed ID: 35572597
[TBL] [Abstract][Full Text] [Related]
24. Combining liquid biopsy and radiomics for personalized treatment of lung cancer patients. State of the art and new perspectives.
Cucchiara F; Petrini I; Romei C; Crucitta S; Lucchesi M; Valleggi S; Scavone C; Capuano A; De Liperi A; Chella A; Danesi R; Del Re M
Pharmacol Res; 2021 Jul; 169():105643. PubMed ID: 33940185
[TBL] [Abstract][Full Text] [Related]
25. Machine Learning-Based Radiomics Signatures for EGFR and KRAS Mutations Prediction in Non-Small-Cell Lung Cancer.
Le NQK; Kha QH; Nguyen VH; Chen YC; Cheng SJ; Chen CY
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502160
[TBL] [Abstract][Full Text] [Related]
26. Identifying sarcopenia in advanced non-small cell lung cancer patients using skeletal muscle CT radiomics and machine learning.
Dong X; Dan X; Yawen A; Haibo X; Huan L; Mengqi T; Linglong C; Zhao R
Thorac Cancer; 2020 Sep; 11(9):2650-2659. PubMed ID: 32767522
[TBL] [Abstract][Full Text] [Related]
27. Radiomic Detection of EGFR Mutations in NSCLC.
Rossi G; Barabino E; Fedeli A; Ficarra G; Coco S; Russo A; Adamo V; Buemi F; Zullo L; Dono M; De Luca G; Longo L; Dal Bello MG; Tagliamento M; Alama A; Cittadini G; Pronzato P; Genova C
Cancer Res; 2021 Feb; 81(3):724-731. PubMed ID: 33148663
[TBL] [Abstract][Full Text] [Related]
28. [Study Progress of Radiomics in Precision Medicine for Lung Cancer].
Shi Z; Zhang X; Jiang T
Zhongguo Fei Ai Za Zhi; 2019 Jun; 22(6):385-388. PubMed ID: 31196373
[TBL] [Abstract][Full Text] [Related]
29. Radiomics features as predictive and prognostic biomarkers in NSCLC.
Bortolotto C; Lancia A; Stelitano C; Montesano M; Merizzoli E; Agustoni F; Stella G; Preda L; Filippi AR
Expert Rev Anticancer Ther; 2021 Mar; 21(3):257-266. PubMed ID: 33216651
[No Abstract] [Full Text] [Related]
30. Imaging Biomarkers in Thoracic Oncology: Current Advances in the Use of Radiomics in Lung Cancer Patients and its Potential Use for Therapy Response Prediction and Monitoring.
Kroschke J; von Stackelberg O; Heußel CP; Wielpütz MO; Kauczor HU
Rofo; 2022 Jul; 194(7):720-727. PubMed ID: 35211928
[TBL] [Abstract][Full Text] [Related]
31. Radiomics for Response and Outcome Assessment for Non-Small Cell Lung Cancer.
Shi L; He Y; Yuan Z; Benedict S; Valicenti R; Qiu J; Rong Y
Technol Cancer Res Treat; 2018 Jan; 17():1533033818782788. PubMed ID: 29940810
[TBL] [Abstract][Full Text] [Related]
32. Multi-level multi-modality (PET and CT) fusion radiomics: prognostic modeling for non-small cell lung carcinoma.
Amini M; Nazari M; Shiri I; Hajianfar G; Deevband MR; Abdollahi H; Arabi H; Rahmim A; Zaidi H
Phys Med Biol; 2021 Oct; 66(20):. PubMed ID: 34544053
[TBL] [Abstract][Full Text] [Related]
33. Radiomics and deep learning in lung cancer.
Avanzo M; Stancanello J; Pirrone G; Sartor G
Strahlenther Onkol; 2020 Oct; 196(10):879-887. PubMed ID: 32367456
[TBL] [Abstract][Full Text] [Related]
34. Artificial Intelligence in Lung Cancer Imaging: From Data to Therapy.
Cellina M; De Padova G; Caldarelli N; Libri D; Cè M; Martinenghi C; Alì M; Papa S; Carrafiello G
Crit Rev Oncog; 2024; 29(2):1-13. PubMed ID: 38505877
[TBL] [Abstract][Full Text] [Related]
35. [Artificial intelligence, radiomics and pathomics to predict response and survival of patients treated with radiations].
Sun R; Lerousseau M; Henry T; Carré A; Leroy A; Estienne T; Niyoteka S; Bockel S; Rouyar A; Alvarez Andres É; Benzazon N; Battistella E; Classe M; Robert C; Scoazec JY; Deutsch É
Cancer Radiother; 2021 Oct; 25(6-7):630-637. PubMed ID: 34284970
[TBL] [Abstract][Full Text] [Related]
36. Radiomics for Predicting Lung Cancer Outcomes Following Radiotherapy: A Systematic Review.
Walls GM; Osman SOS; Brown KH; Butterworth KT; Hanna GG; Hounsell AR; McGarry CK; Leijenaar RTH; Lambin P; Cole AJ; Jain S
Clin Oncol (R Coll Radiol); 2022 Mar; 34(3):e107-e122. PubMed ID: 34763965
[TBL] [Abstract][Full Text] [Related]
37. Discovery radiomics via evolutionary deep radiomic sequencer discovery for pathologically proven lung cancer detection.
Shafiee MJ; Chung AG; Khalvati F; Haider MA; Wong A
J Med Imaging (Bellingham); 2017 Oct; 4(4):041305. PubMed ID: 29021990
[TBL] [Abstract][Full Text] [Related]
38. Radiomics for lung adenocarcinoma manifesting as pure ground-glass nodules: invasive prediction.
Sun Y; Li C; Jin L; Gao P; Zhao W; Ma W; Tan M; Wu W; Duan S; Shan Y; Li M
Eur Radiol; 2020 Jul; 30(7):3650-3659. PubMed ID: 32162003
[TBL] [Abstract][Full Text] [Related]
39. Radiomics as a personalized medicine tool in lung cancer: Separating the hope from the hype.
Fornacon-Wood I; Faivre-Finn C; O'Connor JPB; Price GJ
Lung Cancer; 2020 Aug; 146():197-208. PubMed ID: 32563015
[TBL] [Abstract][Full Text] [Related]
40. Radiomics: an overview in lung cancer management-a narrative review.
Chen B; Yang L; Zhang R; Luo W; Li W
Ann Transl Med; 2020 Sep; 8(18):1191. PubMed ID: 33241040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
